APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Biomarker Testing

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Biomarker Testing Market Outlook and Growth Opportunities 2026

Report ID 173970770419 December 2025198 pages

Choose your research edition.

Industry ResearchBiomarker Testing Industry Research Report 2026102 pages · $2,950 USDIndustry Growth & TrendsGlobal Biomarker Testing Industry Growth and Trends Forecast to 203264 pages · $3,450 USDMarket StructureGlobal Biomarker Testing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032177 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Biomarker Testing Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Biomarker Testing Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Biomarker Testing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Biomarker Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Biomarker Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Biomarker Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Biomarker Testing market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Biomarker Testing market include Agilent Technologies and Roche among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Biomarker Testing market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Biomarker Testing and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Biomarker Testing revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Biomarker Testing market.

Biomarker Testing Segment by Company

Agilent Technologies

Roche

Biomarker Testing Segment by Type

Stroke Testing Biomarkers

Antibiotic Resistance Biomarkers

Antibiotic Stewardship Biomarkers

Traumatic Brain Injury (TBI) Testing Biomarkers

Sepsis Biomarkers

Others

Biomarker Testing Segment by Application

Hospital

Diagnostic Center

Others

Biomarker Testing Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Biomarker Testing status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Biomarker Testing key companies, revenue, market share, and recent developments.

3. To split the Biomarker Testing breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Biomarker Testing market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Biomarker Testing significant trends, drivers, influence factors in global and regions.

6. To analyze Biomarker Testing competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biomarker Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Biomarker Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biomarker Testing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Biomarker Testing industry.

Chapter 3: Detailed analysis of Biomarker Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Biomarker Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Biomarker Testing in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Biomarker Testing Industry Trends Table 2. Biomarker Testing Industry Drivers Table 3. Biomarker Testing Industry Opportunities and Challenges Table 4. Biomarker Testing Industry Restraints Table 5. Global Biomarker Testing Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Biomarker Testing Revenue Share by Company (2021-2026) Table 7. Global Biomarker Testing Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Biomarker Testing Key Company Manufacturing Base & Headquarters Table 9. Global Biomarker Testing Company, Product Type & Application Table 10. Global Biomarker Testing Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Biomarker Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Stroke Testing Biomarkers Table 15. Significant Companies of Antibiotic Resistance Biomarkers Table 16. Significant Companies of Antibiotic Stewardship Biomarkers Table 17. Significant Companies of Traumatic Brain Injury (TBI) Testing Biomarkers Table 18. Significant Companies of Sepsis Biomarkers Table 19. Significant Companies of Others Table 20. Global Biomarker Testing Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 21. Global Biomarker Testing Sales Value by Type (2021-2026) & (US$ Million) Table 22. Global Biomarker Testing Sales Value by Type (2027-2032) & (US$ Million) Table 23. Global Biomarker Testing Sales Value Share by Type (2021-2026) Table 24. Global Biomarker Testing Sales Value Share by Type (2027-2032) Table 25. Significant Companies of Hospital Table 26. Significant Companies of Diagnostic Center Table 27. Significant Companies of Others Table 28. Global Biomarker Testing Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Biomarker Testing Sales Value by Application (2021-2026) & (US$ Million) Table 30. Global Biomarker Testing Sales Value by Application (2027-2032) & (US$ Million) Table 31. Global Biomarker Testing Sales Value Share by Application (2021-2026) Table 32. Global Biomarker Testing Sales Value Share by Application (2027-2032) Table 33. Global Biomarker Testing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Biomarker Testing Sales Value by Region (2021-2026) & (US$ Million) Table 35. Global Biomarker Testing Sales Value Share by Region (2021-2026) Table 36. Global Biomarker Testing Sales Value by Region (2027-2032) & (US$ Million) Table 37. Global Biomarker Testing Sales Value Share by Region (2027-2032) Table 38. Global Biomarker Testing Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Biomarker Testing Sales Value by Country (2021-2026) & (US$ Million) Table 40. Global Biomarker Testing Sales Value Market Share by Country (2021-2026) Table 41. Global Biomarker Testing Sales Value by Country (2027-2032) & (US$ Million) Table 42. Global Biomarker Testing Sales Value Market Share by Country (2027-2032) Table 43. Agilent Technologies Company Information Table 44. Agilent Technologies Business Overview Table 45. Agilent Technologies Biomarker Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. Agilent Technologies Biomarker Testing Product Portfolio Table 47. Agilent Technologies Recent Development Table 48. Roche Company Information Table 49. Roche Business Overview Table 50. Roche Biomarker Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. Roche Biomarker Testing Product Portfolio Table 52. Roche Recent Development Table 53. Research Programs/Design for This Report Table 54. Authors List of This Report Table 55. Secondary Sources Table 56. Primary Sources List of Figures Figure 1. Biomarker Testing Product Image Figure 2. Global Biomarker Testing Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Biomarker Testing Market Size (2021-2032) & (US$ Million) Figure 4. Global Biomarker Testing Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Stroke Testing Biomarkers Image Figure 8. Antibiotic Resistance Biomarkers Image Figure 9. Antibiotic Stewardship Biomarkers Image Figure 10. Traumatic Brain Injury (TBI) Testing Biomarkers Image Figure 11. Sepsis Biomarkers Image Figure 12. Others Image Figure 13. Global Biomarker Testing Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 14. Global Biomarker Testing Sales Value Share 2021 VS 2025 VS 2032 Figure 15. Global Biomarker Testing Sales Value Share by Type (2021-2032) Figure 16. Hospital Image Figure 17. Diagnostic Center Image Figure 18. Others Image Figure 19. Global Biomarker Testing Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Biomarker Testing Sales Value Share 2021 VS 2025 VS 2032 Figure 21. Global Biomarker Testing Sales Value Share by Application (2021-2032) Figure 22. Global Biomarker Testing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 23. Global Biomarker Testing Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 24. North America Biomarker Testing Sales Value (2021-2032) & (US$ Million) Figure 25. North America Biomarker Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Europe Biomarker Testing Sales Value (2021-2032) & (US$ Million) Figure 27. Europe Biomarker Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Asia-Pacific Biomarker Testing Sales Value (2021-2032) & (US$ Million) Figure 29. Asia-Pacific Biomarker Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 30. South America Biomarker Testing Sales Value (2021-2032) & (US$ Million) Figure 31. South America Biomarker Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Middle East & Africa Biomarker Testing Sales Value (2021-2032) & (US$ Million) Figure 33. Middle East & Africa Biomarker Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 34. USA Biomarker Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. USA Biomarker Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. USA Biomarker Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Canada Biomarker Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Canada Biomarker Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Canada Biomarker Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Mexico Biomarker Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Mexico Biomarker Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Mexico Biomarker Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Germany Biomarker Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Germany Biomarker Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Germany Biomarker Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. France Biomarker Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. France Biomarker Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. France Biomarker Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. U.K. Biomarker Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. U.K. Biomarker Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. U.K. Biomarker Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Italy Biomarker Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Italy Biomarker Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Italy Biomarker Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Spain Biomarker Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Spain Biomarker Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Spain Biomarker Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Russia Biomarker Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Russia Biomarker Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Russia Biomarker Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Netherlands Biomarker Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Netherlands Biomarker Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Netherlands Biomarker Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Nordic Countries Biomarker Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Nordic Countries Biomarker Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Nordic Countries Biomarker Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. China Biomarker Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. China Biomarker Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. China Biomarker Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Japan Biomarker Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Japan Biomarker Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Japan Biomarker Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. South Korea Biomarker Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. South Korea Biomarker Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. South Korea Biomarker Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. India Biomarker Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. India Biomarker Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. India Biomarker Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Australia Biomarker Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Australia Biomarker Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Australia Biomarker Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Southeast Asia Biomarker Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Southeast Asia Biomarker Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Southeast Asia Biomarker Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Brazil Biomarker Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Brazil Biomarker Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Brazil Biomarker Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Argentina Biomarker Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Argentina Biomarker Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Argentina Biomarker Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Chile Biomarker Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Chile Biomarker Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Chile Biomarker Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Colombia Biomarker Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Colombia Biomarker Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Colombia Biomarker Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Peru Biomarker Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Peru Biomarker Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Peru Biomarker Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Biomarker Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Saudi Arabia Biomarker Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Saudi Arabia Biomarker Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Israel Biomarker Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Israel Biomarker Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Israel Biomarker Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. UAE Biomarker Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. UAE Biomarker Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. UAE Biomarker Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Turkey Biomarker Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Turkey Biomarker Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Turkey Biomarker Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Iran Biomarker Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Iran Biomarker Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Iran Biomarker Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Egypt Biomarker Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Egypt Biomarker Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Egypt Biomarker Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Years Considered Figure 119. Research Process Figure 120. Key Executives Interviewed

Scope & coverage.

Types
  • Stroke Testing Biomarkers
  • Antibiotic Resistance Biomarkers
  • Antibiotic Stewardship Biomarkers
  • Traumatic Brain Injury (TBI) Testing Biomarkers
  • Sepsis Biomarkers
  • Others
Applications
  • Hospital
  • Diagnostic Center
  • Others
Companies covered
  • Agilent Technologies
  • Roche

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Biomarker Testing Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Biomarker Testing Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Biomarker Testing Market Dynamics
  1. 2.1 Biomarker Testing Industry Trends
  2. 2.2 Biomarker Testing Industry Drivers
  3. 2.3 Biomarker Testing Industry Opportunities and Challenges
  4. 2.4 Biomarker Testing Industry Restraints
3 Biomarker Testing Market by Company
  1. 3.1 Global Biomarker Testing Company Revenue Ranking in 2025
  2. 3.2 Global Biomarker Testing Revenue by Company (2021-2026)
  3. 3.3 Global Biomarker Testing Company Ranking (2024-2026)
  4. 3.4 Global Biomarker Testing Company Manufacturing Base and Headquarters
  5. 3.5 Global Biomarker Testing Company Product Type and Application
  6. 3.6 Global Biomarker Testing Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Biomarker Testing Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Biomarker Testing Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Biomarker Testing Market by Type
  1. 4.1 Biomarker Testing Type Introduction
  2. 4.1.1 Stroke Testing Biomarkers
  3. 4.1.2 Antibiotic Resistance Biomarkers
  4. 4.1.3 Antibiotic Stewardship Biomarkers
  5. 4.1.4 Traumatic Brain Injury (TBI) Testing Biomarkers
  6. 4.1.5 Sepsis Biomarkers
  7. 4.1.6 Others
  8. 4.2 Global Biomarker Testing Sales Value by Type
  9. 4.2.1 Global Biomarker Testing Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Biomarker Testing Sales Value by Type (2021-2032)
  11. 4.2.3 Global Biomarker Testing Sales Value Share by Type (2021-2032)
5 Biomarker Testing Market by Application
  1. 5.1 Biomarker Testing Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Diagnostic Center
  4. 5.1.3 Others
  5. 5.2 Global Biomarker Testing Sales Value by Application
  6. 5.2.1 Global Biomarker Testing Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Biomarker Testing Sales Value by Application (2021-2032)
  8. 5.2.3 Global Biomarker Testing Sales Value Share by Application (2021-2032)
6 Biomarker Testing Regional Value Analysis
  1. 6.1 Global Biomarker Testing Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Biomarker Testing Sales Value by Region (2021-2032)
  3. 6.2.1 Global Biomarker Testing Sales Value by Region: 2021-2026
  4. 6.2.2 Global Biomarker Testing Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Biomarker Testing Sales Value (2021-2032)
  7. 6.3.2 North America Biomarker Testing Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Biomarker Testing Sales Value (2021-2032)
  10. 6.4.2 Europe Biomarker Testing Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Biomarker Testing Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Biomarker Testing Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Biomarker Testing Sales Value (2021-2032)
  16. 6.6.2 South America Biomarker Testing Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Biomarker Testing Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Biomarker Testing Sales Value Share by Country, 2025 VS 2032
7 Biomarker Testing Country-level Value Analysis
  1. 7.1 Global Biomarker Testing Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Biomarker Testing Sales Value by Country (2021-2032)
  3. 7.2.1 Global Biomarker Testing Sales Value by Country (2021-2026)
  4. 7.2.2 Global Biomarker Testing Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Biomarker Testing Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Biomarker Testing Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Biomarker Testing Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Biomarker Testing Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Biomarker Testing Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Biomarker Testing Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Biomarker Testing Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Biomarker Testing Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Biomarker Testing Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Biomarker Testing Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Biomarker Testing Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Biomarker Testing Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Biomarker Testing Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Biomarker Testing Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Biomarker Testing Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Biomarker Testing Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Biomarker Testing Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Biomarker Testing Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Biomarker Testing Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Biomarker Testing Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Biomarker Testing Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Biomarker Testing Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Biomarker Testing Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Biomarker Testing Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Biomarker Testing Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Biomarker Testing Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Biomarker Testing Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Biomarker Testing Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Biomarker Testing Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Biomarker Testing Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Biomarker Testing Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Biomarker Testing Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Biomarker Testing Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Biomarker Testing Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Biomarker Testing Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Biomarker Testing Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Biomarker Testing Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Biomarker Testing Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Biomarker Testing Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Biomarker Testing Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Biomarker Testing Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Biomarker Testing Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Biomarker Testing Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Biomarker Testing Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Biomarker Testing Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Biomarker Testing Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Biomarker Testing Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Biomarker Testing Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Biomarker Testing Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Biomarker Testing Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Biomarker Testing Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Biomarker Testing Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Biomarker Testing Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Biomarker Testing Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Biomarker Testing Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Biomarker Testing Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Biomarker Testing Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Biomarker Testing Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Biomarker Testing Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Biomarker Testing Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Biomarker Testing Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Biomarker Testing Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Biomarker Testing Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Biomarker Testing Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Biomarker Testing Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Biomarker Testing Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Biomarker Testing Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Biomarker Testing Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Biomarker Testing Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Biomarker Testing Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Biomarker Testing Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Biomarker Testing Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Biomarker Testing Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Biomarker Testing Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Biomarker Testing Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Biomarker Testing Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Biomarker Testing Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Biomarker Testing Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Biomarker Testing Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Biomarker Testing Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Biomarker Testing Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Biomarker Testing Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Biomarker Testing Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Biomarker Testing Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Agilent Technologies
  2. 8.1.1 Agilent Technologies Company Information
  3. 8.1.2 Agilent Technologies Business Overview
  4. 8.1.3 Agilent Technologies Biomarker Testing Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Agilent Technologies Biomarker Testing Product Portfolio
  6. 8.1.5 Agilent Technologies Recent Developments
  7. 8.2 Roche
  8. 8.2.1 Roche Company Information
  9. 8.2.2 Roche Business Overview
  10. 8.2.3 Roche Biomarker Testing Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Roche Biomarker Testing Product Portfolio
  12. 8.2.5 Roche Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst